Hyperuricaemia is an liberated risk factor for kidney working decline, and its predominance rises as estimated glomerular filtration rate (eGFR) staging progresses. The study examined hyperuricaemia and other indicators of kidney impairment in sufferers with incessant noncommunicable diseases in a developing frugality. We retrospectively reviewed the dossier collected from a study conducted 'tween January 2014 and December 2014 in which a total of 968 cases with diabetes, hypertension, cardiovascular diseases and incessant kidney affliction (CKD) participated. Each subject provided ancestry sample, which was therefore tested for glucose, antitoxin uric acid, blood urea nitrogen, antitoxin creatinine, lipid profiles, liver enzymes, and albumin. Anthropometric measurements of each subject, containing height, burden, waist circumference, age, common, education level, takeover, and medical history with drug use, were also captured. The result of the study shows that, patients with bred serum uric acid (SUA) levels have larger mean age, systolic blood pressure (SBP), SUA, blood urea nitrogen (BUN), triglycerides, albumin, and very depressed-density lipoprotein cholesterol (VLDL) and lower mean advantage of estimated glomerular filtration rate (e-GFR) compared to cases with rational SUA levels, (P = 0.05). In addition, correlation studies between SUA, e-GFR, BUN, antitoxin creatinine, body bulk index, (BMI), waist circumference (WC) and albumin shows forceful association betwixt SUA and these parameters (p<.0001). About 223 (23.34%) of the CKD patients have nurtured uric acid levels and 745 (76.96%) have normal uric acid levels. Therefore, this study further recorded the well-established association middle from two points hyperuricaemia and CKD. However, the measures already working in lifestyle clinics must be claimed in order to bar any increase in SUA levels in these patients.
Thursday, 16 February 2023
Friday, 14 January 2022
Determination of Hyperuricaemia and Other Correlates of Kidney Impairment in Caribbean Patients with Chronic Noncommunicable Diseases | Chapter 11 | Issues and Development in Health Research Vol. 8
Background: Hyperuricaemia is a risk factor for renal function deterioration that becomes more common as the estimated glomerular filtration rate (eGFR) stage proceeds.
The study's goal is to talk about hyperuricemia and its consequences in patients with chronic noncommunicable diseases in a developing economy.
This retrospective study, which took place between January 2014 and December 2014, comprised 968 individuals with diabetes, hypertension, cardiovascular disease, and chronic renal disease. Glucose, serum uric acid, blood urea nitrogen, serum creatinine, lipid profile, liver enzymes, and albumin were all measured in each subject's blood. Anthropometric indices such height, weight, waist circumference, age, gender, education, occupation, and medical history, including medications, were reported by each participant.
Patients with elevated serum uric acid (SUA) levels have a higher mean age, systolic blood pressure (SBP), SUA, blood urea nitogen (BUN), triglycerides, albumin, and very low density lipoprotein cholesterol (VLDL), as well as a lower mean estimated glomerular filtration rate (e-GFR) (P = 0.05) than patients with normal SUA levels. SUA has a strong relationship with e-GFR, BUN, serum creatinine, body mass index (BMI), waist circumference (WC), and albumin, according to correlation studies (p.0001). Uric acid levels are elevated in 223 (23.34 percent) of chronic kidney disease (CKD) patients, while they are normal in 745 (76.96 percent).
Conclusion: The long-established relationship between hyperuricemia and chronic renal disease is highlighted in this study. However, in order to avoid any trend toward an increase in serum uric acid levels in patients, the measures already in place in lifestyle clinics must be maintained.Author(S) Details
Saleh Idris Tudun Wada
Department of Chemical Pathology, Faculty of Clinical Sciences, Bayero University, Kano, Nigeria.
View Book:- https://stm.bookpi.org/IDHR-V8/article/view/5280
Study on Pattern and Prevalence of Dyslipidemia and Other Cardiovascular Risk Factors among the Various Ethnic Groups of Trinidad and Tobago | Chapter 10 | Issues and Development in Health Research Vol. 8
Background: Dyslipidemia is a crucial component of the metabolic syndrome and has long been linked to the development of issues such as cardiovascular disease (CVD). In addition, there have been reports of differences in the pattern of lipid derangements, particularly between people of African heritage and their South Asian counterparts.
The goal of this study is to highlight the pattern and prevalence of dyslipidemia and other cardiovascular risk factors among Trinidad and Tobago's various ethnic groups.
Materials and Methods: Each of the 968 participants in this study had 10 mL of blood drawn after an overnight fast of 10–12 hours. Plasma and sera were tested for glucose, total cholesterol, triglycerides, high density cholesterol (HDL-c), very low density lipoprotein (VLDL), and low density lipoprotein (LDL) (LDL). Height, weight, waist circumference, age, gender, education, occupation, ethnicity, and medical history, including medications, were all measured in each subject.
Results: Hypertriglyceridemia was found in 33.88 percent of the patients in our study, with the highest prevalence of 46.69 percent seen in South Asians. Body mass index (BMI), systolic blood pressure, blood glucose, triglycerides, and very low-density lipoprotein cholesterol were all different (p 0.05) amongst ethnic groups. However, HDL-c levels were similar across ethnic groups, with the exception that patients of South Asian descent have a trend toward non-significantly greater HDL-c levels than other ethnic groups (p > 0.05).
Conclusion: The study highlighted the well-known considerable discrepancy in lipid profiles amongst people of different ethnic groups in Trinidad and Tobago, particularly among patients with chronic noncommunicable disease (CNCD).Author(S) Details
Idris Saleh
Department of Chemical Pathology, Faculty of Clinical Sciences, Bayero University, Kano, Nigeria.
B. Shivananda Nayak
Department of Pre-Clinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St Augustine Campus, Trinidad and Tobago.
View Book:- https://stm.bookpi.org/IDHR-V8/article/view/5279